The cannabis sector has been coming off its recent highs and this comes as companies are working tirelessly to be prepared for the Canadian recreational cannabis market.
Today, we have highlighted seven company announcements that we believe investors should be aware of.
7 Important Company Developments to Know
- HEXO Corp. (HEXO.TO) (HYYDF) traded slightly higher after announcing plans to establish a Eurozone processing, production and distribution center in Greece. The move will provide the company presence in Europe to supply a full suite of brands in France, the United Kingdom, and other European markets once regulations permit. The agreement calls for the development of 350,000 sq. ft. of licensed infrastructure that will be used for manufacturing, processing and distribution of medical cannabis products for the European market.
- Organigram Holdings Inc. (OGI.V) (OGRMF) edged higher after the Canadian cannabis producer unveiled Trailblazer, the newest addition to their portfolio of products for the recreational cannabis market in Canada. Trailblazer was developed in response to ongoing discussions with Organigram’s jurisdictional and retail partners across Canada and their focus on high value offerings. Earlier this week, Organigram shipped its first order of recreational cannabis to Alberta and has supply agreements or memorandums of understanding with seven provinces including Newfoundland and Labrador, Prince Edward Island, Nova Scotia, New Brunswick, Ontario, Alberta, and Manitoba.
- The Supreme Cannabis Company (FIRE.V) (SPRWF) has been a company to watch and we have been favorable on the continued execution. Yesterday, Supreme announced a $12 million supply agreement with Tilray (TLRY) and the market responded favorably to this. This agreement is a guaranteed commitment to purchase. It will cover the twelve-month period starting October 1, 2018 and we are keeping a close eye on this one.
- Canopy Growth Corporation (WEED.TO) (CGC) approved the previously-announced $5 billion (CAD) private placement of 104,500,000 common shares and 139,745,453 common share purchase warrants to CBG Holdings LLC, an affiliate of Constellation Brands, Inc. (STZ). This private placement was initially reported in August and was a catalyst for the entire cannabis sector. Canopy Growth is the best diversified and best managed Canadian cannabis producer and we are monitoring this one.
- Emerald Health Therapeutics, Inc. (EMH.V) (EMHTF) edged lower after agreeing to purchase CBD-containing hemp biomass for extraction into CBD oil from Emerald Health Hemp Inc. (EHH). Emerald signed an agreement with EHH to purchase approximately 500 acres of chaff in 2018 and approximately 1,000 acres in 2019 to 2022, with an option to renew for an additional two-year period. EHH has established agreements to purchase approximately 500 acres of harvested hemp chaff, plant material consisting mainly of flower and leaf, in Manitoba and Prince Edward Island in 2018, with a plan to expand field operations in 2019. Emerald Health represents a very attractive growth story and we are keeping an eye on how the company continues to execute.
- Choom (CHOO.CN) (CHOOF) announced that it has executed an agreement for cannabis distribution with ParcelPal Technology Inc. (PKG.CN) (PTNYF), a technology driven logistics company that connects consumers with local retailers to get their products delivered quickly and affordably. ParcelPal offers on-demand delivery of merchandise from leading retailers, restaurants, liquor stores and soon medical and recreational marijuana in major cities Canada-wide. Their technology handles the complete requirements of hyperlocal logistics by bringing the merchants and customers onto a single platform. Choom has an attractive relationship with Aurora Cannabis (ACB.TO) (ACBFF) and is in the early innings of a major growth cycle.
- Invictus MD Strategies (GENE.V) (IVITF) completed its first shipment of recreational cannabis to British Columbia on time, following its inaugural shipment to Alberta. This significant milestone was made possible by the company’s balanced and deliberate approach towards cultivation and regulatory compliance. While Invictus focused on expansion of its cultivation facilities, Acreage Pharms secured excise stamps and Health Canada approved packaging for the adult recreational market early, allowing Purchase Orders to be completed on time and without issue. Yesterday, Invictus pulled back after announcing a $20 million bought deal and we think this drop was overdone. We are watching this one!